Microbiological
Quality Control
GMP-compliant microbiological assessments for sterile and non-sterile therapeutic constructs, defending product integrity through rigorous biological screening.
Guarding the Biological Integrity
Biological contamination is one of the most significant risks in pharmaceutical manufacturing. At BrownBiology Laboratory, our specialized microbiology unit provides the definitive verification required for global market release.
Our facilities are fully optimized to handle sterile and non-sterile testing of APIs, raw materials, and finished products. Following EP, USP, and JP standards, we execute high-resolution microbial screenings and environmental monitoring programs.
Talk to the Microbiology Team 鈫?/a>
Primary Testing Hub
Maintaining absolute biological control across every pharmaceutical dimension.
Sterility & Endotoxins
Comprehensive sterility testing for injectable and ophthalmic products, combined with LAL kinetic-turbidimetric or chromogenic endotoxin quantification.
Microbial Limit Testing (MLT)
Vetting non-sterile products for microbial enumeration and specific microorganism detection (E. coli, S. aureus, P. aeruginosa, etc.) according to ICH.
Bioburden & Bioburden ID
Quantifying microbial populations in raw materials, in-process samples, and finished products, including phenotypic and genotypic identification.
Environmental Monitoring
Critical assessment of cleanroom air, surfaces, and water systems to ensure aseptic manufacturing environments remain strictly within specifications.
Specialized Methodologies
Beyond standard pharmacopoeial testing, we execute complex growth promotion studies, preservative efficacy (PET) assessments, and customized disinfectant verification modules tailored to your specific facility layouts and product matrices.